867166-09-4 Usage
Uses
Used in Pharmaceutical Industry:
8-chloro-3-cyclobutylimidazo[1,5-a]pyrazine is used as a potential candidate for the development of new drugs and pharmaceutical products due to its distinctive chemical structure and properties. Its exploration in this field is driven by the need for novel compounds that can address various medical conditions and improve treatment options.
Used in Drug Research and Development:
In the context of drug research and development, 8-chloro-3-cyclobutylimidazo[1,5-a]pyrazine serves as a valuable compound for further study. Its unique features make it an interesting subject for investigation, with the potential to contribute to advancements in medicinal chemistry and the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 867166-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,1,6 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 867166-09:
(8*8)+(7*6)+(6*7)+(5*1)+(4*6)+(3*6)+(2*0)+(1*9)=204
204 % 10 = 4
So 867166-09-4 is a valid CAS Registry Number.
867166-09-4Relevant academic research and scientific papers
Fused bicyclic mTOR inhibitors
-
Page/Page column 53, (2008/06/13)
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
UNSATURATED mTOR INHIBITORS
-
Page/Page column 42-43, (2010/11/28)
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS
-
Page/Page column 432, (2008/06/13)
Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein XI, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
